|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/196 | |||
| A61K 39/395 | |||
| A61P 5/00 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2114432 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07854968.0 |
| Europos patento paraiškos padavimo data | 2007-12-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-11-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/086550 |
| Data | 2007-12-05 |
| (87) | Numeris | WO 2008/070743 |
| Data | 2008-06-12 |
| (30) | Numeris | Data | Šalis |
| 868716 P | 2006-12-05 | US |
| (72) |
PRUSSAK, Charles E., US
|
| (73) |
Memgen LLC,
402 West Broadway, Suite 400, San Diego, CA 92101,
US
|
| (54) | METHODS OF INCREASING CANCER SENSITIVITY TO CHEMOTHERAPEUTIC AGENTS USING CHIMERIC ISF35 |
| METHODS OF INCREASING CANCER SENSITIVITY TO CHEMOTHERAPEUTIC AGENTS USING CHIMERIC ISF35 |